Thank you, Chair.
Thank you, witnesses, for being here today.
Mr. LeRoux, earlier submissions by organizations linked to the chemistry association of Canada had concerns with the proposed watch-list—namely, redundancy and a lack of clarity regarding the listing of substances. Does the CPCA share any of those concerns?